CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MODICELL project focuses on enhancing cell-based immunotherapies for cancer treatment and organ transplantation. It aims to optimize immune cell responses by understanding their complex regulation, ultimately improving patient-specific therapies through a multidisciplinary approach that combines academic research a…
Cell-based immunotherapies are a modern treatment approach holding promise to utilize nature’s own power to treat diseases that develop on the ground of immune system aberrations.
Such diseases include cancer that develops and progresses via immune escape and on the other hand rejection of transplanted organs that need to be accepted by the immune system.
Because the functions of distinct immune cell populations are highly plastic and interdependent, a better understanding of the complex regulat…
ST ANNA KINDERKREBSFORSCHUNG VEREIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Austria, WIEN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finland, HELSINKI
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Israel, Ramat Gan
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Finland, HELSINKI
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
